Cytek Biosciences shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $574k | 63k | 9.12 |
| 2023-09-30 | $348k | 63k | 5.52 |
| 2023-06-30 | $538k | 63k | 8.54 |
| 2023-03-31 | $561k | 61k | 9.19 |
| 2022-12-31 | $623k | 61k | 10.21 |
| 2022-09-30 | $898k | 61k | 14.71 |
| 2022-06-30 | $655k | 61k | 10.73 |
| 2022-03-31 | $590k | 55k | 10.78 |
| 2021-12-31 | $105k | 6.4k | 16.28 |
| 2021-09-30 | $138k | 6.4k | 21.41 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors